Dr. Kyle Lester

Dr. Kyle Lester
Dr. Kyle Lester joined the Urology Group in 2023. He was born and raised in Bluefield, WV. His interest for medicine began at an early age as the son of a small-town general surgeon. He earned a bachelor of arts in German and a minor in Economics from Sewanee and went on to complete medical school at the Edward Via Virginia College of Osteopathic Medicine. Dr. Lester was active in the Student Osteopathic Surgical Association acting as the vice president for the local chapter, and graduated magna cum laude. He completed his urological surgery residency at the Einstein Healthcare Network in Philadelphia, PA in 2019. He received excellent training in all aspects of urology, particularly endourology, prosthetics and reconstruction, oncology and general urology. His training also included time at the Children’s Hospital of Philadelphia and Fox Chase Cancer Center. After residency, he completed an additional year of fellowship training in robotics and urologic oncology at the Cleveland Clinic Foundation Florida in 2020. His robotics training was primarily focused on robotic radical prostatectomy and kidney surgery. After fellowship Dr. Lester accepted a position in 2020 with the Central Ohio Urology Group located in Columbus, OH. He spent two and half years with the practice before moving back to Virginia. Dr. Lester and his wife are excited to be closer to family and friends. Dr. Lester prides his practice on shared decision making and spending time with patients. His areas of interest include general urology, transperineal prostate biopsy, robotic kidney and prostate surgery, surgical management of stone disease and minimally invasive BPH. He resides in Northern Virginia with his wife and two children.Dr. Lester enjoys soccer, snow skiing, running, the outdoors, triathlons, German culture and spending time with family.
Medical School:

Edward Via Virginia College of Osteopathic Medicine


Einstein Healthcare Network

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only